Sergio Cannata

Mr. Sergio Cannata

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2023 in Sensors
Verified
Journal Article
Open access
PDF file
Cirrincione GiansalvoCirrincione Giansalvo
Cirrincione Giansalvo
SCSergio Cannata
Sergio Cannata
Giovanni CicceriGiovanni Cicceri
Giovanni Cicceri
FPFrancesco Prinzi
Francesco Prinzi
TCTiziana Currieri
Tiziana Currieri
SVSalvatore Vitabile
Salvatore Vitabile
Melanoma is a malignant cancer type which develops when DNA damage occurs (mainly due to environmental factors such as ultraviolet rays). Often, melanoma results in intense and aggressive cell growth that, if not caught in time, can bring one toward death. Thus, early identification at the initial stage is fundamental to stopping the spread of cancer. In this paper, a ViT-based architecture able to classify melanoma versus non-cancerous lesions is presented. The proposed predictive model is trained and tested on public skin cancer data from the ISIC challenge, and the obtained results are highly promising. Different classifier configurations are considered and analyzed in order to find the most discriminating one. The best one reached an accuracy of 0.948, sensitivity of 0.928, specificity of 0.967, and AUROC of 0.948.

1 November 2023 in Sensors
Verified
Journal Article
Open access
PDF file
Eros PaseroEros Pasero
Eros Pasero
FGFiorenzo Gaita
Fiorenzo Gaita
VRVincenzo Randazzo
Vincenzo Randazzo
PMPierre Meynet
Pierre Meynet
SCSergio Cannata
Sergio Cannata
CGCarla Giustetto
Carla Giustetto
Short QT syndrome (SQTS) is an inherited cardiac ion-channel disease related to an increased risk of sudden cardiac death (SCD) in young and otherwise healthy individuals. SCD is often the first clinical presentation in patients with SQTS. However, arrhythmia risk stratification is presently unsatisfactory in asymptomatic patients. In this context, artificial intelligence-based electrocardiogram (ECG) analysis has never been applied to refine risk stratification in patients with SQTS. The purpose of this study was to analyze ECGs from SQTS patients with the aid of different AI algorithms to evaluate their ability to discriminate between subjects with and without documented life-threatening arrhythmic events. The study group included 104 SQTS patients, 37 of whom had a documented major arrhythmic event at presentation and/or during follow-up. Thirteen ECG features were measured independently by three expert cardiologists; then, the dataset was randomly divided into three subsets (training, validation, and testing). Five shallow neural networks were trained, validated, and tested to predict subject-specific class (non-event/event) using different subsets of ECG features. Additionally, several deep learning and machine learning algorithms, such as Vision Transformer, Swin Transformer, MobileNetV3, EfficientNetV2, ConvNextTiny, Capsule Networks, and logistic regression were trained, validated, and tested directly on the scanned ECG images, without any manual feature extraction. Furthermore, a shallow neural network, a 1-D transformer classifier, and a 1-D CNN were trained, validated, and tested on ECG signals extracted from the aforementioned scanned images. Classification metrics were evaluated by means of sensitivity, specificity, positive and negative predictive values, accuracy, and area under the curve. Results prove that artificial intelligence can help clinicians in better stratifying risk of arrhythmia in patients with SQTS. In particular, shallow neural networks’ processing features showed the best performance in identifying patients that will not suffer from a potentially lethal event. This could pave the way for refined ECG-based risk stratification in this group of patients, potentially helping in saving the lives of young and otherwise healthy individuals.

11 November 2022 in IEEE Access
Verified
Journal Article
Open access
SCSergio Cannata
Sergio Cannata
APAnnunziata Paviglianiti
Annunziata Paviglianiti
Eros PaseroEros Pasero
Eros Pasero
GCGiansalvo Cirrincione
Giansalvo Cirrincione
Maurizio CirrincioneMaurizio Cirrincione
Maurizio Cirrincione
Coronavirus disease (COVID-19) was confirmed as a pandemic disease on February 11, 2020. The pandemic has already caused thousands of victims and infected several million people around the world. The aim of this work is to provide a Covid-19 infection screening tool. Currently, the most widely used clinical tool for detecting the presence of infection is the reverse transcription polymerase chain reaction (RT-PCR), which is expensive, less sensitive and requires the resource of specialized medical personnel. The use of X-ray images represents one of the latest challenges for the rapid diagnosis of the Covid-19 infection. This work involves the use of advanced artificial intelligence techniques for diagnosis using algorithms for classification purposes. The goal is to provide an automatic infection detection method while maximizing detection accuracy. A public database was used which includes images of COVID-19 patients, patients with viral pneumonia, patients with pulmonary opacity, and healthy patients. The methodology used in this study is based on transfer learning of pre-trained networks to alleviate the complexity of calculation. In particular, three different types of convolutional neural networks, namely, InceptionV3, ResNet50 and Xception, and the Vision Transformer are implemented. Experimental results show that the Vision Transformer outperforms convolutional architectures with a test accuracy of 99.3% vs 85.58% for ResNet50 (best among CNNs). Moreover, it is able to correctly distinguish among four different classes of chest X-ray images, whereas similar works only stop at three categories at most. The high accuracy of this computer-assisted diagnostic tool can significantly improve the speed and accuracy of COVID-19 diagnosis.


1 January 2022 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
SCSergio Cannata
Sergio Cannata
APAnnunziata Paviglianiti
Annunziata Paviglianiti
EPEros G. Pasero
Eros G. Pasero
GCGiansalvo Cirrincione
Giansalvo Cirrincione
Coronavirus disease (COVID-19) was confirmed as a pandemic disease on February 11, 2020. The pandemic has already caused thousands of victims and infected several million people around the world. The aim of this work is to provide a Covid-19 infection screening tool. Currently, the most widely used clinical tool for detecting the presence of infection is the reverse transcription polymerase chain reaction (RT-PCR), which is expensive, less sensitive and requires the resource of specialized medical personnel. The use of X-ray images represents one of the latest challenges for the rapid diagnosis of the Covid-19 infection. This work involves the use of advanced artificial intelligence techniques for diagnosis using algorithms for classification purposes. The goal is to provide an automatic infection detection method while maximizing detection accuracy. A public database was used which includes images of COVID-19 patients, patients with viral pneumonia, patients with pulmonary opacity, and healthy patients. The methodology used in this study is based on transfer learning of pre-trained networks to alleviate the complexity of calculation. In particular, three different types of convolutional neural networks, namely, InceptionV3, ResNet50 and Xception, and the Vision Transformer are implemented. The high accuracy of this computer-assisted diagnostic tool can significantly improve the speed and accuracy of COVID-19 diagnosis.